ID
45159
Beschreibung
Principal Investigator: Christopher Haiman, ScD, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA MeSH: Prostatic Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000306 Multiple GWA studies of prostate cancer conducted in European White populations are ongoing. These studies will continue to have a dramatic impact on our understanding of the contribution of common genetic variation on inter-individual susceptibility to this common cancer. Important questions that will remain unanswered, however, are whether all common risk alleles for prostate cancer will be revealed in studies limited to populations of European ancestry. A comprehensive examination of common genetic variation in men of Japanese, Latino, and African ancestry will be required to understand population differences in disease risk and to reveal the full spectrum of causal alleles that exist in these populations. Further, genetic and environmental diversity is likely to contribute to ethnic heterogeneity of genetic effects. Elucidating gene x gene and gene x environment interactions is also likely to provide knowledge that may be critical for understanding the contribution of genetic susceptibility to racial/ethnic disparities in prostate cancer incidence and for translating the findings from GWA studies into interventions. In this study we plan to undertake a genome-wide association study (GWAS) of prostate cancer in the Multiethnic Cohort (MEC) Study. We propose the following hypotheses: (a) that inherited DNA variation influences risk of prostate cancer; (b) that many of the causal alleles will be outside known "candidate genes" requiring an agnostic, comprehensive search; and (c) that performing this search in a multi-ethnic cohort is more powerful than a study limited to a single population to reveal the full range of causal alleles relevant to the U.S. population. The version 1 release of this dataset will include genotype data for the Japanese and Latino populations in the study. The version 2 release will include data for the African ancestry population along with the Japanese and Latino subjects. The version 3 release will include fully-cleaned genotype data for all three populations. This study is part of the Gene Environment Association Studies initiative (GENEVA, http://www.genevastudy.org) funded by the trans-NIH Genes, Environment, and Health Initiative (GEI). The overarching goal is to identify novel genetic factors that contribute to prostate cancer through large-scale genome-wide association studies of a well-characterized multi-ethnic cohort. Genotyping was performed at the Broad Institute of MIT and Harvard, a GENEVA genotyping center and at the University of Southern California. Data cleaning and harmonization were performed at the GEI-funded GENEVA Coordinating Center at the University of Washington. As an add-on to this GWAS we performed a targeted re-sequencing of all known prostate cancer risk loci in the samples from the MEC. Sequencing was performed in Dr. Reich's lab at Harvard Medical School.
Link
Stichworte
Versionen (2)
- 30.08.22 30.08.22 - Simon Heim
- 12.10.22 12.10.22 - Adrian Schulz
Rechteinhaber
Christopher Haiman, ScD, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
Hochgeladen am
12. Oktober 2022
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
dbGaP phs000306 A Multiethnic GWAS of Prostate Cancer
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent groups, and subject sources of Japanese, Latino, and African American participants with or without prostate cancer and associated with MEC and non MEC studies.
- Pedigree of Japanese and Latino participants with or without prostate cancer and associated with MEC study.
- Sample ID, subject ID, and sample source of Japanese, Latino, and African American participants with or without prostate cancer and associated with MEC and non MEC studies.
- Body mass index, diet, smoking, drinking, and physical activity of Japanese and Latino participants with or without prostate cancer and associated with MEC study.
- Body mass index, diet, smoking, drinking, and physical activity of African Americans with or without prostate cancer and associate with MEC study.
- Subject ID, study ID, case or control status, ethnicity, and age of onset of African Americans with or without prostate cancer and associated with non MEC study.
- Sample ID, analyte type, body site where from samples were collected, tumor status of samples obtained from participants with or without prostate cancer and associated with MEC and non MEC studies.
Ähnliche Modelle
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent groups, and subject sources of Japanese, Latino, and African American participants with or without prostate cancer and associated with MEC and non MEC studies.
- Pedigree of Japanese and Latino participants with or without prostate cancer and associated with MEC study.
- Sample ID, subject ID, and sample source of Japanese, Latino, and African American participants with or without prostate cancer and associated with MEC and non MEC studies.
- Body mass index, diet, smoking, drinking, and physical activity of Japanese and Latino participants with or without prostate cancer and associated with MEC study.
- Body mass index, diet, smoking, drinking, and physical activity of African Americans with or without prostate cancer and associate with MEC study.
- Subject ID, study ID, case or control status, ethnicity, and age of onset of African Americans with or without prostate cancer and associated with non MEC study.
- Sample ID, analyte type, body site where from samples were collected, tumor status of samples obtained from participants with or without prostate cancer and associated with MEC and non MEC studies.
C0600139 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C0231290 (UMLS CUI [1,4])
C1512693 (UMLS CUI [1,5])
C0599755 (UMLS CUI [1,6])
C0150103 (UMLS CUI [1,2])
C0009932 (UMLS CUI [1,3])
C1706256 (UMLS CUI [1,4])
C3853635 (UMLS CUI [1,5])
C0237096 (UMLS CUI [1,6])
C0001779 (UMLS CUI [1,7])
C0680251 (UMLS CUI [2,1])
C0009932 (UMLS CUI [2,2])
C0011900 (UMLS CUI [2,3])
C0600139 (UMLS CUI [2,4])
C0332152 (UMLS CUI [2,5])
C1512693 (UMLS CUI [2,6])
C0599755 (UMLS CUI [2,7])
C0034394 (UMLS CUI [2,8])
C0805443 (UMLS CUI [2,9])
Keine Kommentare